
|Articles|June 2, 2003
Pharmacy appeals claim standard turndown
A coalition of pharmacy groups plans to appeal a rejection of its effort to overturn the mandated use of the 5.1 Rx claim standard developed by the National Council for Prescription Drug Programs (NCPDP).
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Merck Shares Access Strategy for Investigational Monthly PrEP Alimatravir
2
Post-Pandemic Vaccine Gaps Mirror Socioeconomic Disparities
3
FDA Approves First-in-Class Centanafadine for Treatment of ADHD
4
FDA Approves Gwyn Lo, a Once Weekly Low-Dose Estrogen Contraceptive Patch
5























